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Abbreviations: HSCR, Hirschsprung’s disease; CO, carbon monoxide; NO, nitric oxide; HO-
2, heme oxygenase-2; nNOS, neuronal nitric oxide synthase; ENS, enteric nervous system; 
NANC, nonadrenergic noncholinergic; NPY, neuropeptide Y; VIP, vasoactive intestinal 
peptide; ATP, adenosine tri-phosphate; ENK, enkephaline; LCM, laser capture micro-
dissection; RT-PCR, reverse transcription-polymerase chain reaction. 
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Abstract 
Hirschsprung’s disease (HSCR) is characterized by the absence of ganglion cells and 
impaired relaxation of the gut. Nitric oxide (NO), and more recently, carbon monoxide (CO) 
have been identified as inhibitory neurotransmitters causing relaxation. A deficiency in NO 
has been reported in aganglionic gut; we hypothesized that CO could also be involved in 
impaired gut motility in HSCR. The aim of the study was to determine the distribution of CO- 
and NO-producing enzymes in the normal and aganglionic gut. We performed laser capture 
micro-dissection, reverse transcription-polymerase chain reaction, and immunohistochemistry 
on colon biopsies of normal controls (n=9) and patients with HSCR (n=10). The mRNA 
expression of heme oxygenase-2 (HO-2), immunoreactivities of HO-2 and NO synthase, was 
determined and compared. Results show a high level of expression of HO-2 mRNA was 
localized in the myenteric plexus. Expression of HO-2 mRNA was also detected in the 
mucosa, submucosa and the muscular layer. Down-regulation of the expression of HO-2 
mRNA was detected in the aganglionic colon. Immunoreactivities of HO-2 and NO synthase 
were mainly localized to the ganglion plexus, and nerve fibers within the muscle in the 
control colons and normoganglionic colons of the patients. HO-2-containing neurons were 
more abundant than NO synthase-containing neurons in the myenteric plexus. Nearly all the 
NO synthase-containing neurons also had HO-2.  HO-2 and NO synthase were selectively 
absent in the myenteric and submucosal regions, and in the muscle of the aganglionic colon. 
Our findings suggest the involvement of both CO and NO in the pathophysiology of HSCR. 
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Introduction 
Hirschsprung’s disease (HSCR) is a developmental disorder that is characterized by 
the deficiency of ganglion cells in the myenteric plexus and submucosal plexus of the distal 
colon.  The distal aganglionic colon in patients with HSCR appears spastic. It is believed that 
the colon spasm, which causes bowel obstruction, is the result of the circular and longitudinal 
smooth muscle of the colon not relaxing. Gut peristalsis is mediated by a reflex pathway 
within the enteric nervous system (ENS) that can function autonomously, without any input 
from the central nervous system. The neurons of the ENS reside in two types of plexuses, 
namely the myenteric and submucosal plexuses. The former is between the outer longitudinal 
and inner circular muscle layer, and the latter is in the submucosal region of the gut. The 
myenteric and submucosal plexuses are interconnected with intrinsic nerve fibers and form 
the entire neural network encompassing the full length of the digestive tract. Peristalsis, a 
rhythmic contraction and relaxation of the two muscle layers of the gut wall, propels the gut 
content in the lumen uni-directionally.  The contraction and relaxation of the two muscle 
layers are mediated respectively by the activities of the excitatory and inhibitory nerves of the 
ENS.  
In normal bowel, relaxation is mediated, at least in part, by nonadrenergic 
noncholinergic (NANC) nerve. Gaseous molecules of nitric oxide (NO) and carbon monoxide 
(CO) are neurotransmitters of NANC neurons.  NO and CO are produced by neuronal nitric 
oxide synthase (nNOS) and heme oxygenase-2 (HO-2), respectively in NANC neurons. The 
physiological functions of CO and NO in smooth muscle relaxation of the gastrointestinal 
tract have been demonstrated in genetically engineered mice that do not possess HO-2 and/or 
nNOS activity12,39.  NANC mediated relaxation stimulated by 1’1-dimethyl-4 
phenylpiperazinium (DMPP) or electrical field stimulation (EFS) in the gut and isolated 
smooth muscle cells were substantially suppressed in the HO-2 and nNOS deficient mice35,39.   
 4
The effect of the absence of CO in the intestinal relaxation was dramatic and the overall 
transit through the gastrointestinal tract was significantly slower in the HO-2 deficient mice.  
The absence of NO had a milder and more localized effect and the nNOS deficient mice 
exhibited delayed gastric emptying with nearly normal transit through the intestine and colon.  
Immunohistochemical and histochemical studies of the aganglionic colon of patients 
with HSCR have indicated the absence of nitric oxide producing nerves in the plexus area and 
in the musculature of the aganglionic colon23,30.  Functional studies have shown that the 
internal anal sphincter of patients with HSCR is not responsive to the exogenous NO, 
suggesting that NO alone is not sufficient to restore the neural deficit2,3.  This could be 
explained by a recent finding, that the nNOS-NO system cannot function unless CO is a 
coneurotransmitter, and that the effects of CO and NO on muscle relaxation are shown to be 
additive35.  In line with the proposed coneurotransmitter function of CO and NO, HO-2 and 
nNOS have been colocalized in the ganglionic plexuses of the anorectum in opossum1, and 
the stomach and jejunum in humans21.  In order to investigate the role of CO and NO in the 
pathophysiology of HSCR, we determined the distribution of HO-2, and nNOS in the colon of 
patients with and without HSCR using laser capture micro-dissection, reverse transcription-
polymerase chain reaction (RT-PCR), and immunohistochemistry.  
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Materials and methods 
Samples collection 
Fresh resected specimens of colon were collected from 10 patients with HSCR. Analysis of 
the rectal biopsy samples of these patients revealed an absence of ganglion cells. Hematoxylin 
and eosin staining, and acetylcholinesterase histochemical staining on rectal biopsies of 
patients with HSCR performed by pathologists, confirmed the diagnosis of HSCR in all 10 
cases (Table 1). Site-matched specimens of the colon from seven age-matched infants with 
conditions unrelated to HSCR were included as controls (imperforate anus, n=6; necrotizing 
enterocolitis, n=1); two adults patients with rectal cancer were separately studied as alternate 
controls. These control colon specimens were obtained from normal colons proximal to and 
well away from the diseased bowel; histological analysis of control specimens confirmed no 
dysganglionosis. Tissue samples were divided for mRNA experiments studies and 
immunohistochemistry.  
 
 
Tissue preparation for RNA extraction 
Full-thickness specimens from the normoganglionic, hypoganglionic, and aganglionic zones 
of the bowel of each patient with HSCR and the colons of normal controls were used for RNA 
extraction using Trizol (Life Technologies, Rockville, MD). The study was approved by the 
Ethics Committee of the University of Hong Kong, Faculty of Medicine, and tissues were 
obtained with patients’ informed consent. 
 
Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) 
First strand cDNA was synthesized from 1 μg of total RNA using oligo d(T)12-18 as a reverse 
primer (SuperScript® Preamplification System, Life Technologies). Expression of HO-2 and 
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β-actin were analyzed using PCR. PCR was performed in 25 μl of standard buffer containing 
primers (1 μM each), 3 μl of cDNA, 0.5 units of AmpliTaq polymerase (Life Technologies), 
MgCl2 (1.5 mM), and dNTP (0.2 mM). After the initial denaturation at 94°C for three 
minutes, PCR was performed for 30 cycles for HO-2 and β-actin as follows: 30 seconds 
denaturation at 94°C; one minute annealing at 60°C; 1 minute extension at 72°C for each 
cycle. A final extension for 10 minutes at 72°C was added. Details of PCR primers and sizes 
of the RT-PCR products were depicted as shown in Table 2.   PCR primers for HO-2 and β-
actin genes were specially designed to span at least two exons.  With exon-spanning PCR 
primers, PCR products using the genomic DNA as template would be bigger than those from 
cDNA and therefore could be readily resolved by gel electrophoresis.  The PCR products 
were analyzed by electrophoresis in a 1% agarose gel. Intensities of PCR bands were 
quantified and relative expression levels of HO-2 to β-actin were determined using Scion 
Image software and the comparative method as described by Nicoletti and Sassy-Prigeut22.  
 
Laser Capture Microdissection (LCM) and RT-PCR 
In order to determine and compare the expression of HO-2 in different regions of human 
colon, we performed LCM and semi-quantitative RT-PCR analysis. Mucosa, submucosa, 
muscle, and myenteric plexus of the colon were excised from the cryosections of normal 
colon of three controls for total RNA extraction and semi-quantitative RT-PCR analysis. 
Relative expression of HO-2 to the house-keeping gene, β-actin, in various excised regions 
was determined and compared. Colon specimens were embedded in OCT (Sakura Finetek 
USA Inc. Torrance, USA) and snap frozen in liquid nitrogen before storage at -80°C. 
Cryosections (12 μm) were prepared on cryotome and mounted on the polythylene membrane 
of a histology slide. The sections were stained briefly with hematoxylin and dried completely. 
Defined regions of the gut were dissected with the PALM LCM (P.A.L.M. Mikrolaser 
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Technologie, Germany). The mucosa (epithelium layer and lamina propria), submucosa, 
muscles (circular and longitudinal layers), and myenteric plexus were dissected. Total RNA 
was isolated from the dissected regions using a Stratagene® micro RNA isolation kit 
following the manufacturer’s protocol (Stratagene Cloning Systems, La Jolla, USA).  Semi-
quantitative RT-PCR analysis of the expression of HO-2 in different regions of the colon was 
performed as described above. 
 
Statistic analysis 
Means and standard error of the mean (SEM) of the relative expression of HO-2 to β-actin 
were determined for each group. Wilcoxon signed rank test was performed using GraphPAD 
PRISM software (GraphPAD Software, San Diego, CA) to evaluate the significance of the 
differences between the relative expression of HO-2 in various segments of patients with 
HSCR.  Unpaired Student t test was performed to evaluate the significance of the differences 
between the relative expression of HO-2 in normoganglionic segments of patients with HSCR 
and normal control bowels.  
 
Immunohistochemistry 
Tissues were fixed in 4% formaldehyde/PBS (phosphate buffered saline, pH 7.2) for 16 hours 
before embedding in paraffin, and sections (4 μm) were prepared. Antigen unmasking was 
performed by heating the slides for five minutes at 95°C in 10mM citrate buffer (pH 6).  The 
sections were incubated in 3% hydrogen peroxide in methanol (v/v) to quench the 
endogenous peroxidase activity. Blocking of sections, incubation of antibodies, and color 
development were performed using the DAKO EnVisionTM+ System, HRP (Dako A/S, 
Glostrup, Denmark). Anti HO-2 polyclonal antibody (Stressgen®; 1:12,000)(StressGen, 
Victoria BC, Canada) and anti nNOS antibody (Santa Cruz; 1: 4000)(Santa Cruz 
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Biotechnology, CA, USA) were incubated with the slides at ambient temperature for two 
hours. Sections were counterstained with haematoxylin, dehydrated, cleared in xylene and 
mounted in DPX mountant (BDH Laboratory Supplies, Poole, Dorset, UK). Semiquantitation 
of HO-2 and nNOS immunopositive neurons within the myenteric plexus of normal human 
colon were made by counting cell in 6 randomly selected sections. Two observers counted 
separately and the results were compared. 
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Results  
Differential distribution of HO-2 transcript in normal human colon 
Laser capture microdissection allowed different regions of colon to be accurately separated 
for mNRA experiment analysis.  To quantify the expression level of HO-2 in different regions 
of the gut, we determined the relative expression levels of HO-2 using β-actin as an internal 
control. The β-actin gene encodes a nonmuscle cytoskeletal actin that is expressed 
constitutively in all cell types, and β-actin gene has been widely used as an internal control 
for semi-quantitative RT-PCR analysis. No amplified product was obtained in negative 
controls in which the reverse transcriptase was omitted (data not shown). This indicates that 
the amplicons observed in our samples were not PCR products of the contaminating genomic 
DNA. HO-2 transcripts were detected in the mucosa, submucosa, muscle, and myenteric 
plexus. The highest level of expression of HO-2 was detected in the myenteric plexus (Figure 
1). The findings in the infant and adult controls were similar.   
 
Down-regulation of HO-2 in aganglionic colon of patients with HSCR 
To determine if CO is involved in the pathophysiology of HSCR, we used a semi-quantitative 
RT-PCR method to determine and compare the expression of HO-2 in full-thickness 
specimens from the normoganglionic and aganglionic colon of patients with HSCR (n=10), 
and the colon of controls (n=9) (Figure 2). The ratio of HO-2/β-actin was 0.27±0.06 
(means±SEM), 0.50±0.18 (means±SEM), and 0.59±0.21 (means±SEM) in the aganglionic, 
normoganglionic colon of patients with HSCR, and colon of controls, respectively. The 
relative expression of HO-2 in the aganglionic colon was significantly lower than that in the 
normoganglionic colon of patients with HSCR (p=0.03). The relative expression of HO-2 was 
however not significantly different between the normoganglionic colon of patients with 
HSCR and the control colons (p=0.77). 
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 Distribution of HO-2 and nNOS immunoreactivity in the colon of patients with HSCR 
and in controls 
HO-2 and nNOS immunoreactivity were mainly localized in the neuronal cell bodies of the 
myenteric plexus and submucosal plexus of the colon, and the nerve fibers within the 
longitudinal and circular muscles (Figure 3). HO-2 and nNOS immunoreactivity was also 
present in the cell bodies and the processes of enteric neurons, in the nerve fascicles of the 
plexus. 
The ganglion plexuses in the gut are composed of two morphologically distinct cell 
types: glial cells and neurons. The nuclei of glial cells are smaller and slightly elongated while 
the nuclei of neurons are bigger and round. Within the myenteric plexus, HO-2 
immunoreactive enteric neurons were more abundant than the nNOS immunoreactive enteric 
neurons (means, 82.5% versus 57%).  On the contrary, HO-2 immunoreactive nerve fibers 
were much less abundant that nNOS immunoreactive nerve fibers in the muscle. In addition 
to the enteric ganglion plexus, HO-2 immunoreactivity was also present in the mucosal 
epithelium, lamina propria, and the endothelial cells of submucosal blood vessels (Figure 3). 
Immunoreactivity of nNOS was localized to a few mucosal epithelial cells, and endothelial 
cells of submucosal blood vessels (Figure 3). 
 Immunohistochemistry was performed on adjacent sections to investigate the 
colocalization of HO-2 and nNOS in the colon. Within the myenteric plexus, nearly all the 
nNOS immunoreactive neurons also contained HO-2 (Figure 4).  In contrast, neurons that 
only showed immunoreactivity for HO-2 and not for nNOS were found in the myenteric 
plexus.  Numerous neurons were immunoreactive for both HO-2 and nNOS in the submucosal 
plexus (data not shown).   
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The distribution of HO-2 and nNOS immunoreactivity in normoganglionic colons of 
patients with HSCR was identical to that of controls (data not shown). In contrast, HO-2 and 
nNOS immunoreactivity was completely absent from the submucosal and myenteric regions 
of the aganglionic colon (Figure 5C, F). No HO-2 and nNOS immunoreactive nerve fibers 
could be localized within the longitudinal and circular muscles in the aganglionic colon 
(Figure 5C, F). Instead, weak HO-2 and nNOS immunoreactivity was detected in the 
hypertrophic nerve trunks, in the myenteric and submucosal regions of the aganglionic colon 
(Figure 5C, F). A gradual reduction of HO-2 and nNOS immunoreactivity in the myenteric 
region, and in the nerve fibers within the muscle, occurred from the hypoganglionic to the 
aganglionic colon (Figure 5).  HO-2 and nNOS immunoreactivity at the mucosal epithelium 
and the submucosal blood vessels was unaffected in the aganglionic colon, indicating that the 
lack of HO-2 and nNOS immunoreactivity in the myenteric and submucosal regions, and in 
the muscle nerve fibers were not experimental artefacts (data not shown).  No signal was 
observed on the negative control sections if the primary antibody was omitted (data not 
shown). 
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Discussion 
Nitric oxide (NO) and carbon monoxide (CO) are considered as neurotransmitters in 
the central, peripheral, and enteric nervous systems5,8,25,33,39.  In the gastrointestinal tract, CO 
and NO that are released from the inhibitory nonadrenergic noncholinergic (NANC) neurons 
of the ENS diffuse into adjacent smooth muscle cells. CO or NO binds and activates an 
enzyme guanylate cyclase, in the cytoplasm of the muscle cells. Activated guanylate cyclase 
catalyses the formation of guanosine 3’, 5’-cyclic monophosphate (cGMP) from guanosine 
monophosphate (GMP). High intracellular cGMP causes relaxation of the muscle cells.  The 
effects of CO and NO in the relaxation of the smooth muscles of the gastrointestinal tract 
have been demonstrated in mice25,35,39, in the internal anal sphincters in opossums4, and in 
colon of human2,3. A deficiency of NO-producing neurons has been reported in aganglionic 
colons of patients with Hirschsprung’s disease (HSCR)23,30.  However, the distribution of CO-
producing neurons in the ENS of the normal and aganglionic colon has not been described.  
Our present study provides data on the detailed localization of both CO- and NO-producing 
neurons in the ENS of the normal human colon, and in the normoganglionic and aganglionic 
colon of patients with HSCR. 
The immunoreactivity of HO-2 and nNOS was mainly localized in neuronal cell 
bodies of the myenteric plexus and submucosal plexus of the colon, and in the nerve fibers 
within the longitudinal and circular muscles. Semi-quantitative RT-PCR analysis of the 
micro-dissected regions of normal colon using a laser capture micro-dissection (LCM) 
technique also showed a high level of mRNA expression of HO-2 in the myenteric plexus and 
muscle. 
Our immunohistochemical study indicated that approximately 82.5% and 57% of 
enteric neurons showed HO-2 and nNOS immunoreactivity respectively in the myenteric 
plexus of the human colon. Numerous neurons were found to be immunoreactive for both 
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HO-2 and nNOS in the submucosal plexus.  Our finding of an abundance of HO-2 
immunoreactive neurons in myenteric plexus of colon is comparable to previous findings in 
the human antrum and jejunum. The percentages of HO-2 containing neurons in the myenteric 
plexuses of the antrum and jejunum were 77% and 92% respectively20.  Our data showed that 
nearly all the nNOS immunoreactive neurons also contained HO-2.  A high degree of 
colocalization of HO-2 and nNOS immunoreactivity in neurons has also been observed in the 
human antrum and jejunum20, in the human urethral sphincter11, and in the anorectum of 
opossums1.  Data from this and other studies suggest a high percentage of enteric neurons 
produce both CO and NO.  Colocalization of CO- and NO- producing systems in the enteric 
neurons has important functional implications. This is in line with recently evidence that 
suggest the nNOS-NO system cannot function without CO as a coneurotransmitter35.  
Semi-quantitative RT-PCR analysis showed that the expression level of HO-2 mRNA 
in the normoganglionic colon of patients with HSCR was comparable to that in the colon of 
normal controls.  However, HO-2 was significantly down-regulated in the aganglionic colon 
of all 10 patients with HSCR.  Furthermore, the distribution of HO-2 and nNOS 
immunoreactivity in the normoganglionic colon of patients with HSCR was identical to that 
of the controls. In contrast, HO-2 and nNOS immunoreactivity was completely absent from 
the myenteric and submucosal regions of the aganglionic colon.  No HO-2 and nNOS 
immunoreactive nerve fibers could be localized within the muscles in the aganglionic colon.  
Our data showed that CO- and NO- producing neurons were selectively absent in the enteric 
nervous system of the aganglionic colon of patients with HSCR.  In aganglionic colon, the 
intramural regions are replaced with hypertrophic nerve trunks. The hypertrophied nerve 
trunks consist of cholinergic nerve fibres that have been shown to be extrinsic 
parasympathetic nerve fibres of sacral origin15,29.  The hypertrophic nerve trunks in the 
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aganglionic bowel were weakly immunopositive for HO-2 and nNOS indicating that the 
extrinsic neural components also synthesize and secrete CO and NO as neurotransmitters.   
In addition to CO and NO, neurotransmitters such as neuropeptide Y (NPY); 
vasoactive intestinal peptide (VIP); adenosine tri-phosphate (ATP) and enkephaline (ENK) 
have also been identified in the inhibitory NANC neurons7.  Bowel innervation consists of 
intrinsic and extrinsic neural components that include ganglion cells, nerve fibres and 
supporting cells.  In the aganglionic bowel of Hirschsprung’s disease, there is a deficiency of 
intrinsic nerve cells and nerve processes arising from these cells but not necessary a 
deficiency of other components.  While there is reduction of VIP6,17,27, substance P (SP) 
17,27,28, and gastrin-releasing peptide (GRP)17 in aganglionic bowel, calcitonin gene-related 
peptide (CGRP) and galanin18 levels are unchanged, and NPY9,16, somatostatin19 and 
chromogranin26 levels are increased. This indicates that a deficiency of intrinsic neural 
components does not necessary result in a pan-reduction of all neurotransmitters in the 
aganglionic bowel. The individual roles of various neural components in the pathogenesis of 
Hirschsprung’s disease remain to be dissected. 
CO and NO have been shown to account for most of the NANC neurotransmission in 
the gut, suggesting CO and NO are the major neurotransmitters of NANC neurons of the 
ENS39.  Recently, interstitial cells of Cajal (ICC) were shown to contain HO-2 and nNOS in 
the gastrointestinal tract in mice, canine, humans, and opossum1,20,24,34. CO and NO may serve 
as an intercellular transmitter between myenteric neurons and ICC, and between ICC and 
smooth muscle cells.  ICC are found throughout the whole gastrointestinal tract and is 
required for normal gut motility.  A deficiency in ICC has been reported in human gut 
motility disorders including HSCR32,36,37, pseudo-obstruction13,14,38, infantile pyloric 
stenosis31, and slow transit constipation10.  Therefore, it is likely that a deficiency in CO and 
NO could cause functional deficiency of inhibitory NANC neurons and ICC in the 
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aganglionic colon. This, in turn, manifests as gut dysmotility and functional obstruction in 
patents with HSCR.   
Our data suggest that CO, in addition to NO, may play a role in the pathophysiology 
of Hirschsprung’s disease.  The role of CO and NO in the pathology of other human gut 
motility disorders such as slow transit constipation, pseudo-obstruction requires additional 
study. 
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Legends 
Figure 1. Differential expression of HO-2 in the myenteric plexus of the human colon. The 
hematoxylin and eosin stained cryosection (4μm) of the colon of a normal control. The 
mucosa, submucosa, muscle, and myenteric plexuses (arrowhead) of the colon (marked with 
lines) were excised with LCM (left panel). RNA was prepared from the excised gut regions 
for RT-PCR analysis for HO-2 and β-actin. Amplicons of HO-2 and β-actin were resolved by 
agarose gel electrophoresis. A typical gel picture of the RT-PCR analysis is shown (top right 
panel). The RT-PCR bands were quantified, and the relative expressions of HO-2 to β-actin in 
each region were calculated and are shown as a bar graph (bottom right panel). Scale bar 
represents 50 μm. 
Figure 2. Down-regulation of HO-2 in the aganglionic colon of patient with Hirschsprung’s 
disease. A typical gel picture of the RT-PCR results of HO-2 and β-actin of RNA isolated 
from the colon of a normal control (C); normoganglionic (N); hypoganglionic (H), and 
aganglionic (A) colon of a patient with Hirschsprung’s disease (top panel). The RT-PCR 
bands were quantified, and the relative expressions of HO-2 to β-actin in various segments 
were calculated and shown as a bar graph (bottom panel). A total of 10 patients with 
Hirschsprung’s disease and seven age-matched controls were recruited in the present analysis. 
The relative expression of HO-2 in aganglionic colon was significantly lower than that in the 
normoganglionic colon of patients with Hirschsprung’s disease (p<0.05). 
Figure 3. Immunohistochemical analysis of HO-2 and nNOS in normal colon. The 
immunoreactivity of HO-2 and nNOS (arrowheads) was detected in the mucosa, submucosal 
plexuses, nerves fibers in the muscle layer, and myenteric plexus. Scale bars represent 50 μm. 
Figure 4. Colocalization of HO-2 and nNOS in the ganglion plexuses. The nNOS 
immunoreactive neurons were usually immunoreactive for HO-2 (arrowheads). Neurons that 
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only showed immunoreactivity for HO-2 and not for nNOS were found in the myenteric 
plexus (unfilled arrowheads). Scale bars represent 50 μm.  
Figure 5. Gradual reduction of HO-2 and nNOS immunoreactivity from the hypoganglionic to 
the aganglionic colon. Immunostaining of HO-2 (A, B, C) and nNOS (D, E, F) in the 
hypoganglionic gut (A, D), aganglionic gut (C, F), and the transitional zone between the 
hypoganglionic and aganglionic colon (B, E). HO-2 and nNOS immunoreactive nerve fibres 
and plexuses (arrowheads) were found in the hypoganglionic colon (A, D). HO-2 and nNOS 
immunoreactive nerve fibers were scarce in the transitional zone (B, E).  The hypertrophic 
nerve trunk (unfilled arrowhead) was weakly immunoreactive for HO-2 and nNOS in the 
aganglionic colon (C, F). Scale bars represent 50 μm. 
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 Table 1. Clinical data of the patients with HSCR 
Case No. Age 
(months) 
Sex Familial (F) 
Sporadic (S)
Diagnosis 
4668 10.5 M S Short HSCR 
4765 11 F S Long HSCR 
5055 10 M S Short HSCR 
5585 50.5 M S Short HSCR 
6297 39.5 M S Short HSCR 
7853 5 M S Long HSCR 
8444 9.5 M S Short HSCR 
B100 3.5 F S Short HSCR 
B131 17.5 M S Short HSCR 
B241 3.5 F S Short HSCR 
 
Detail including age, sex, familial or sporadic and diagnosis of HSCR are shown. 
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Table 2. PCR primers for human HO-2 and β-actin  
Gene Primer Position Product 
HO-2 F: 5’-AGGAAATGGAGCGCAACA-3’ (exon 3) 
R: 5’-GAAAGGGCATTTACGCATGTC-3’ (exon 4) 
332-349 
885-865 
554 bp 
β-actin F: 5’-GTGGGGCGCCCCAGGCACCA-3’ (exon 2) 
R: 5’-CTCCTTAATGTCACGCACGATTTC-3’ (exon 4) 
176-195 
715-692 
450 bp 
 
Nucleotide positions of primers for HO-2 and β-actin were numbered from the published 
mRNA sequences NM_002134 and NM_001101 in NCBI, respectively.  Amplicon sizes were 
indicated in base pairs (bp). 
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